Steris (STE) FCF Payout Ratio (2018 - 2026)
Steris' quarterly FCF Payout Ratio came in at 0.58 in Q4 2025, down 34.3% year-on-year from 0.89 in Q4 2024, and down 290.23% quarter-over-quarter from 0.31 in Q3 2025.
Steris has reported FCF Payout Ratio for 8 years, with the latest figure at 0.58 in Q4 2025.
- For the quarter ending Q4 2025, FCF Payout Ratio fell 34.3% year-over-year to 0.58; the trailing twelve-month figure through Dec 2025 stood at 0.24 (up 223.27% YoY), and the FY2025 full-year result was 0.28, up 10997.35% from the prior year.
- FCF Payout Ratio for Q4 2025 stood at 0.58, down from 0.31 in the prior quarter.
- The five-year high for FCF Payout Ratio was 2.23 in Q3 2022, with the low at 0.94 in Q1 2023.
- Average FCF Payout Ratio over 5 years is 0.29, with a median of 0.3 recorded in 2025.
- Year-over-year, FCF Payout Ratio soared 1289.31% in 2022 and tumbled 316.08% in 2023.
- Tracing STE's FCF Payout Ratio over 5 years: stood at 0.26 in 2021, then jumped by 56.48% to 0.41 in 2022, then retreated by 27.7% to 0.3 in 2023, then slumped by 246.07% to 0.44 in 2024, then sank by 34.3% to 0.58 in 2025.
- The last three FCF Payout Ratio figures came in at 0.58 (Q4 2025), 0.31 (Q3 2025), and 0.17 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.20 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.81 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.40 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.08 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.25 |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 0.15 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.25 |
| Dec 31, 2025 | -0.58 |
| Sep 30, 2025 | 0.31 |
| Jun 30, 2025 | 0.17 |
| Mar 31, 2025 | 1.15 |
| Dec 31, 2024 | -0.44 |
| Sep 30, 2024 | 0.38 |
| Jun 30, 2024 | 0.26 |
| Mar 31, 2024 | -0.90 |
| Dec 31, 2023 | 0.30 |
| Sep 30, 2023 | 0.82 |
| Jun 30, 2023 | 0.22 |
| Mar 31, 2023 | -0.94 |
| Dec 31, 2022 | 0.41 |
| Sep 30, 2022 | 2.23 |
| Jun 30, 2022 | 0.37 |
| Mar 31, 2022 | 0.44 |
| Dec 31, 2021 | 0.26 |
| Sep 30, 2021 | 0.46 |
| Jun 30, 2021 | 0.83 |
| Mar 31, 2021 | 0.03 |
| Dec 31, 2020 | -0.43 |
| Sep 30, 2020 | 0.29 |
| Jun 30, 2020 | 0.47 |
| Mar 31, 2020 | -0.65 |
| Dec 31, 2019 | 0.41 |
| Sep 30, 2019 | 0.31 |
| Jun 30, 2019 | 0.48 |
| Dec 31, 2018 | -0.66 |
| Sep 30, 2018 | 0.32 |
| Jun 30, 2018 | 0.36 |